Fleming R H, Jennison S H, Naunheim K S
Department of Surgery, St. Louis University Medical Center, MO 63110-0250.
Ann Thorac Surg. 1994 May;57(5):1300-1. doi: 10.1016/0003-4975(94)91379-x.
An increased risk of neoplasia is a well-recognized complication of chronic immunosuppression. Although lung cancer has been sporadically reported in the transplant population, it has not been recognized widely as a specific risk among heart transplant recipients. We present 3 cases of bronchogenic carcinoma in cardiac transplant patients, discuss possible risk factors, and outline recommendations for diagnosis and management of new lung lesions discovered during routine follow-up.